TI
CGEM icon

Trexquant Investment’s Cullinan Oncology CGEM Stock Holding History

Trexquant Investment’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.39M Sell
168,473
-213,062
-56% -$2.74M 0.02% 928
2025
Q4 		$3.95M Buy
381,535
+193,917
+103% +$1.75M 0.04% 701
2025
Q3 		$1.11M Buy
187,618
+68,276
+57% +$500K 0.01% 1116
2025
Q2 		$899K Buy
119,342
+50,875
+74% +$409K 0.01% 1139
2025
Q1 		$518K Buy
+68,467
New +$657K 0.01% 1265
2024
Q1 		– Sell
-34,955
Closed -$356K – 1459
2023
Q4 		$356K Buy
+34,955
New +$310K 0.01% 1202
2023
Q1 		– Sell
-10,249
Closed -$108K – 1469
2022
Q4 		$108K Sell
10,249
-13,408
-57% -$163K ﹤0.01% 1313
2022
Q3 		$303K Sell
23,657
-8,194
-26% -$110K 0.01% 1034
2022
Q2 		$408K Buy
+31,851
New +$361K 0.02% 945

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return